AI 检索
AI 阅读
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.
研究兴趣

论文共 14 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Abstract 3135: BSI-730, a bispecific antibody targeting HER2 and PD-L1 for the development of a first-in-class bispecific ADC
Xiaoyao Hao, Hongyan Li, Xiaodong F. Liu, Jinyu Liu, Wenwen Dai, Ying Pan, Hui-Han Hu, Jun Li,Shukai Xia, Qun Lyu,Hugh M. Davis,Mingjiu Chen,
Cancer Researchno. 6_Supplement (2024): 3135-3135
引用0浏览0引用
0
0
Abstract 5298: BSI-093, a best-in-class anti-BTN3A monoclonal antibody for cancer immunotherapy by activation of Vg9Vd2 T cells
Wenwen Dai, Jun Li, Jinyu Liu, Hongyan Li, Xiaodong F. Liu,Shukai Xia, Qun Lyu,Hugh M. Davis,Mingjiu Chen,Zeyu Peng
Cancer Researchno. 6_Supplement (2024): 5298-5298
引用0浏览0引用
0
0
Abstract 1343: BSI-111, a highly selective anti-CD16a monoclonal antibody with potent agonist activity for building a NK cell engager platform
Jinyu Liu, Wenwen Dai, Hongyan Li, Xiaodong F. Liu, Jun Li,Shukai Xia, Qun Lyu,Hugh M. Davis,Mingjiu Chen,Zeyu Peng
Cancer Researchno. 6_Supplement (2024): 1343-1343
引用0浏览0引用
0
0
Abstract 6367: BSI-507, a first-in-class bispecific antibody targeting PD1 and PVRIG for cancer immunotherapy
Zeyu Peng, Xiaodong F. Liu,Hongyan Li, Wenwen Dai, Jinyu Liu, Xiaoyao Hao,Shukai Xia, Qun Lv,Hugh M. Davis,Mingjiu Chen, Z. Mark
Cancer Researchno. 7_Supplement (2023): 6367-6367
引用0浏览0引用
0
0
BSI-508, a novel bispecific fusion molecule targeting PD1 and CD47 for cancer immunotherapy
Zeyu Peng, Xiaodong F. Liu,Hongyan Li, Wenwen Dai, Jinyu Liu, Xiaoyao Hao,Shukai Xia, Qun Lv,Hugh M. Davis,Mingjiu Chen, Mark Z. Ma
CANCER RESEARCHno. 7 (2023)
引用0浏览0引用
0
0
1176 BSI-510, a novel bispecific molecule combining an anti-Siglec-15 antibody with cytokine GM-CSF for enhanced antitumor efficacy
Hongyan Li, Zemeng Ma, Xiaoyao Hao, Xiaodong F Liu, Wenwen Dai,Yuxiang Liu,Jinyu Liu,Shukai Xia, Mark Z Ma,Mingjiu Chen,Zeyu Peng
Journal for ImmunoTherapy of Cancerno. Suppl 1 (2023)
引用0浏览0引用
0
0
Abstract 2958: BSI-508, a novel bispecific fusion molecule targeting PD1 and CD47 for cancer immunotherapy
Zeyu Peng, Xiaodong F. Liu,Hongyan Li, Wenwen Dai, Jinyu Liu, Xiaoyao Hao,Shukai Xia, Qun Lv,Hugh M. Davis,Mingjiu Chen, Z. Mark
Cancer Researchno. 7_Supplement (2023): 2958-2958
引用0浏览0引用
0
0
加载更多
作者统计
  • 合作者
  • 学生
  • 导师
暂无相似学者，你可以通过学者研究领域进行搜索筛选
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn